✦ LIBER ✦

Study of the resistance of tumor-cell spheroids to penetration and lysis by activated effector cells

✍ Scribed by Tomasz Ochalek; Sabine von Kleist

Publisher: John Wiley and Sons
Year: 1994
Tongue: French
Weight: 848 KB
Volume: 57
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910570318

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody-mediated target cell lysis by n

Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations

✍ E. W. Gelfand; K. Resch; Marlot Prester 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Glycoproteic nature of surface molecules

Glycoproteic nature of surface molecules of effector cells with lymphokine-activated killer (LAK) activity. Evidence that T11, T8 or T3 molecules are not involved in tumor-cell lysis by LAK effector T cells

✍ Marcello Bagnasco; Maria Cristina Mingari; Daniela Pende; Daniela Venuti; Giorgi 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

Human peripheral blood mononuclear cells cultured in the presence of interleukin-2 (IL-2) acquire the capability of lysing NK-resistant fresh tumor target cells. in an attempt to (leiin-Isolation and culture of peripheral blood mononuclear cells eate the surface structure(s) present on the effector

Simultaneous targeting of IL2 and IL12 t

Simultaneous targeting of IL2 and IL12 to Hodgkin's lymphoma cells enhances activation of resting NK cells and tumor cell lysis

✍ Andreas Hombach; Claudia Heuser; Hinrich Abken 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB

## Abstract Hodgkin's disease (HD) is characterized by the accumulation of functionally anergic T cells in the vicinity of the malignant Hodgkin/Reed‐Sternberg (H/RS) cells. To revert cellular anergy against H/RS cells, we generated an anti‐CD30‐antibody‐interleukin‐(IL)‐2 and an anti‐CD30‐antibody

Bispecific antibodies reactive with the

Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cells

✍ J. van Dijk; T. Tsuruo; D. M. Segal; R. L. H. Bolhuis; R. Colognola; R. J. van d 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

## We describe the lysis of multidrug-resistant (MDR) tumor cells by various lymphocytic effector cells, retargeted with bispecific antibodies (heteroconjugates). The Ab -heteroconjugate used was prepared by chemically cross-linking the OKT3 monoclonal antibody (MAb) reactive with CD3 antigen on T

Lysis of tumor biopsy cells by blood lym

Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies

✍ Farkas Vánky; Maria Grazia Masucci; Maria Teresa Bejarano; Eva Klein 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 691 KB

Blood lymphocyte subsets of various densities from 14 healthy donors and 25 patients with solid tumors were used in tests for cytotoxicity against allogeneic or autologous tumor cells. The allogeneic combinations comprised 36 tests on 28 tumors. In these the unmanipulated total lymphocyte population

Study of the susceptibility of human col

Study of the susceptibility of human colorectal tumor explants to lak-cell lysis: Comparison of various cytotoxicity tests

✍ Tomasz Ochalek; Dr. Sabine Von Kleist 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

The susceptibility of tumor cells from cultures of 8 human colorectal tumor explants to a standard LAK preparation originating from a single healthy donor was assessed in 5 various cytotoxic tests. Target cells were suspended or attached (in three different 51Cr-release 4 hr tests), grown as a confl